Ipamorelin/Tesamorelin Blend 5mg/5mg
Two peptides, two receptor systems, one vial. Ipamorelin is a selective ghrelin receptor (GHS-R) agonist — a pentapeptide that triggers GH release without touching cortisol or prolactin. Tesamorelin is a 44-amino-acid GHRH analog with a lipophilic trans-3-hexenoic acid cap that shields it from aminopeptidase degradation. They work through entirely different receptor mechanisms within the somatotropic axis, which is precisely the point of co-formulating them. Buy Ipamorelin/Tesamorelin Blend 5mg/5mg
Component breakdown
Ipamorelin (5mg)
Selective GHS-R agonist pentapeptide. CAS 170851-70-4. MW 711.85 g/mol. Characterized by Raun et al. as the first GH secretagogue with selectivity comparable to GHRH itself.
Tesamorelin (5mg)
Full-length GHRH analog (all 44 amino acids) with N-terminal lipophilic stabilization. CAS 218949-48-5. MW 5135.83 g/mol. A structurally different approach to GHRH receptor agonism than the truncated, tetra-substituted CJC-1295.
Why this pairing
GHRH receptor activation and ghrelin receptor signaling converge on pituitary somatotrophs through complementary cascades. Preclinical literature has characterized how these two inputs interact — the GHRH pathway through cAMP/PKA, the GHS-R pathway through PLC/IP3/calcium. Studying both under identical experimental conditions in a single reconstitution eliminates variability from separate preparations. Buy Ipamorelin/Tesamorelin Blend 5mg/5mg
Ipamorelin/Tesamorelin Blend 5mg/5mg Specifications
| Content | 5mg Ipamorelin + 5mg Tesamorelin per vial |
| Format | Co-lyophilized powder |
| Testing | Third-party tested, both components verified |
Storage
- Lyophilized: -20°C
- Reconstituted: 2-8°C, use within 30 days
For laboratory research use only. Not for human or veterinary use.




Reviews
There are no reviews yet.